Market Trends of China Patient Monitoring Industry
This section covers the major market trends shaping the China Patient Monitoring Market according to our research experts:
Cardiology is Expected to Have Significant Share in the Market During the Forecast Period
Cardiac monitoring refers to continuous or intermittent monitoring of heart activity with an assessment of the patient's condition relative to their cardiac rhythm. Additional monitoring components allow cardiovascular pressures and cardiac output to be monitored and displayed as required for patient diagnosis and treatment. Continuous cardiovascular and pulmonary monitoring allows for prompt identification and initiation of treatment.
The increasing prevalence of various heart diseases and rising demand for patient monitoring to manage cardiovascular disease efficiently are expected to contribute to the growth of the studied segment. For instance, the NCBI article published in January 2021 mentioned that in 2021, of the 290 million patients with cardiovascular disease patients in China, heart stroke affected nearly 13 million, coronary heart disease affected about 11 million, pulmonary heart disease affected approximately 4.5 million, affected over 2 million and others. Additionally, the data published by WPR in 2022 shows that one in every five adults in China had some cardiovascular disease in 2022. the report also mentioned a 50% increase in cardiovascular disease by 2030. Such increasing prevalence of cardiovascular diseases among the Chinese population is expected to drive the demand for patient monitoring, thereby contributing to the market's growth.
Neurology is Expected to Hold Notable Share in the Market Over the Forecast Period
The Neurology branch of healthcare deals with various neurological such as migraine, epilepsy, Alzheimer, Parkinson's diseases, acute spinal cord injury, ataxia, and others. The increasing prevalence of the above-mentioned neurological disorders among the Chinese population is expected to contribute to the increase in the demand for patient monitoring devices, thereby contributing to the growth of the studied segment.
For instance, as per the article published by ST in November 2022, an estimated 10 million Alzheimer's patients are in china in 2022 and this number is expected to rise to 40 million by 40 million. Similarly, the Plos One article published in April 2021 mentioned that china had approximately 10 million people with epilepsy in 2021. Such prevalence of various neurological disorders among the Chinese population is expected to drive the demand for neurology monitoring among the patients, thereby contributing to the growth of the studied segment.
Also, the rising geriatric population who are most susceptible to developing neurological disorders in old age is expected to contribute to the growth of the studied segment. For instance, the data published by VC in May 2021, mentioned that the number of people aged 60 years and older was 17.9% of the Chinese population this share is expected to reach 34.6% by 2050.
Thus, the increasing prevalence of various neurological disorders, along with the rising geriatric population is expected to drive the demand for patient monitoring devices, thereby fueling the segment growth.
